SOUTH SAN FRANCISCO, CA: Company Updates Clinical Trials and Regulatory Plans Related to the Development of CK-2017357 in ALS Patients; Reductions in Spending Enable Prioritization and Advancement of Skeletal Muscle Activator ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.